http://www.ambergen.com/wp-content/uploads/logo-retina.png 0 0 Kenneth Rothschild http://www.ambergen.com/wp-content/uploads/logo-retina.png Kenneth Rothschild2013-08-27 13:41:552017-03-02 20:23:05AmberGen receives US Patent 8,507,648 for novel method of detecting protease activity using mass spectrometry
Get in Touch
313 Pleasant St.
Watertown, MA 02472
- Dr. Gargey Yagnik joins AmberGen as Program Coordinator for Mass Spectrometry. In his previous position as a postdoctoral researcher at Sanofi Genzyme he developed new methods for MALDI-MSI tissue imaging. He received his Ph.D. from Iowa State University in analytical chemistry. January 2017
- AmberGen awarded two US Patents (9,334,530 and 9,523,680) providing broad coverage for its Bead-AMS™ technology December 2016